STAR*D: what have we learned?
Publication
, Journal Article
Rush, AJ
Published in: Am J Psychiatry
February 2007
Duke Scholars
Published In
Am J Psychiatry
DOI
ISSN
0002-953X
Publication Date
February 2007
Volume
164
Issue
2
Start / End Page
201 / 204
Location
United States
Related Subject Headings
- Venlafaxine Hydrochloride
- Treatment Outcome
- Tranylcypromine
- Secondary Prevention
- Research Design
- Randomized Controlled Trials as Topic
- Psychiatry
- Lithium Compounds
- Humans
- Follow-Up Studies
Citation
APA
Chicago
ICMJE
MLA
NLM
Rush, A. J. (2007). STAR*D: what have we learned? Am J Psychiatry, 164(2), 201–204. https://doi.org/10.1176/ajp.2007.164.2.201
Rush, A John. “STAR*D: what have we learned?” Am J Psychiatry 164, no. 2 (February 2007): 201–4. https://doi.org/10.1176/ajp.2007.164.2.201.
Rush AJ. STAR*D: what have we learned? Am J Psychiatry. 2007 Feb;164(2):201–4.
Rush, A. John. “STAR*D: what have we learned?” Am J Psychiatry, vol. 164, no. 2, Feb. 2007, pp. 201–04. Pubmed, doi:10.1176/ajp.2007.164.2.201.
Rush AJ. STAR*D: what have we learned? Am J Psychiatry. 2007 Feb;164(2):201–204.
Published In
Am J Psychiatry
DOI
ISSN
0002-953X
Publication Date
February 2007
Volume
164
Issue
2
Start / End Page
201 / 204
Location
United States
Related Subject Headings
- Venlafaxine Hydrochloride
- Treatment Outcome
- Tranylcypromine
- Secondary Prevention
- Research Design
- Randomized Controlled Trials as Topic
- Psychiatry
- Lithium Compounds
- Humans
- Follow-Up Studies